NARI Inari Medical

Inari Medical to Announce First Quarter 2024 Financial Results

Inari Medical to Announce First Quarter 2024 Financial Results

IRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) --  Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its first quarter 2024 financial results on Tuesday, April 30, 2024. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Interested parties may access the live call via telephone by dialing 844-825-9789 for domestic callers or 412-317-5180 for international callers. The live webinar may be accessed by visiting the Events Section of the Inari investor relations website or by registering . A replay of the webinar will be available shortly after the conclusion of the call and will be archived on Inari’s website.

About Inari Medical, Inc.

Patients first. No small plans. Take care of each other. These are the guiding principles that form the ethos of Inari Medical. We are committed to improving lives in extraordinary ways by creating innovative solutions for both unmet and underserved health needs. In addition to our purpose-built solutions, we leverage our capabilities in education, clinical research, and program development to improve patient outcomes. We are passionate about our mission to establish our treatments as the standard of care for venous disease, including venous thromboembolism, chronic venous disease and beyond. We are just getting started. Learn more at and connect with us on , , and .

Investor Contact:

John Hsu, CFA

VP, Investor Relations

949-658-3889



EN
17/04/2024

Underlying

NARIInari Medical

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Inari Medical

 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical to Announce First Quarter 2024 Financial Results

Inari Medical to Announce First Quarter 2024 Financial Results IRVINE, Calif., April 17, 2024 (GLOBE NEWSWIRE) --  Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced that it will release its first quarter 2024 financial results on Tuesday, April 30, 2024. In conjunction with the release, Inari will host a conference call and webcast at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights. Interested par...

April 17, 2024 1 EN
 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical Announces the Release of 2023 Ethos and Sustainability R...

Inari Medical Announces the Release of 2023 Ethos and Sustainability Report IRVINE, Calif., April 11, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today announced the publication of its 2023 Ethos and Sustainability Report. The report highlights Inari’s commitment to its ethos and important corresponding environmental, social and governance (ESG) initiatives. The report can be found on Inari’s website “We are proud to issue our third an...

April 11, 2024 1 EN
 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical Strengthens Senior Leadership Team with Addition of Two ...

Inari Medical Strengthens Senior Leadership Team with Addition of Two Executives IRVINE, Calif., April 02, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), today announced the appointment of Tim Benner as Senior Vice President of U.S. Sales and Dr. Andrew Niekamp as Vice President of Medical Affairs. Mr. Benner will be responsible for developing effective strategies across the company's multi-product sales platform and leading a high-performance commercial team to drive therapy penetration. Dr. Niekamp will be instrumental in advancing Inari’s mission to improve pati...

April 2, 2024 1 EN
 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical Announces Interim Two-Year Results from the ClotTriever ...

Inari Medical Announces Interim Two-Year Results from the ClotTriever CLOUT Registry Rates of Post Thrombotic Syndrome at two years were excellent and significantly lower than rates reported in historical Deep Vein Thrombosis trials IRVINE, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced positive two-year interim results from the CLOUT registry. The data was presented at the American Venous Forum ...

March 12, 2024 1 EN
 PRESS RELEASE
Free
NARI INARI MEDICAL

Inari Medical Reports Fourth Quarter 2023 Financial Results

Inari Medical Reports Fourth Quarter 2023 Financial Results IRVINE, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and transform the lives of patients suffering from venous and other diseases, today reported financial results for its fourth quarter and full year ended December 31, 2023. Fourth Quarter Financial and Recent Business Highlights Generated revenue of $132.1 million in Q4 of 2023, up 22.6% over the same quarter last year.GAAP operating loss was $9.3 million in Q4 of 2023, compared to a $...

February 28, 2024 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch